Solventum Corp is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: SOLV's Q1 FY2026 results showed significant earnings deterioration with net income plunging 90.5% YoY to $13M on a 3.0% revenue decline to $2.007B, driven by a sharp 7.5% rise in SG&A expenses and negative operating cash flow of -$189M, though the balance sheet improved materially with long-term debt cut by 41.4% and stockholders' equity up 52.3%.
Drawn from management commentary in the Q1 2026 10-Q:
Total revenue fell 3.0% YoY to $2.007B in Q1 FY2026 from $2.070B in the prior-year period, suggesting softening demand or pricing pressure in SOLV's core markets. Despite the revenue decline, gross margin actually improved modestly by approximately 84 basis points to 54.7%, indicating some resilience in pricing or product mix.
SG&A expenses rose sharply by 7.5% YoY to $827M, significantly outpacing revenue trends and acting as the primary driver of operating income's 46.7% collapse to $81M. This cost inflation likely reflects increased selling investments, restructuring-related costs, or elevated administrative expenses following the company's separation or transformation activities.
Net income dropped 90.5% YoY to just $13M, with diluted EPS falling from $0.78 to $0.07, reflecting the combined impact of lower revenue, higher SG&A, and potentially elevated interest or other below-the-line charges. The net margin compressed dramatically to just 0.65% from an estimated 6.6% in the prior-year period.
Revenue
$2.01B
-3.04% YoY
EPS (Basic)
$0.07
-91.14% YoY
Gross Margin
54.7%
++0.84% YoY
Operating Income
$81M
-46.71% YoY
Add SOLV to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.